Overview
Karishma Mehra is a Hematologist and an Oncologist in Hartford, Connecticut. Dr. Mehra is rated as an Experienced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). Her top areas of expertise are Breast Cancer, Angiosarcoma, Paget Disease of the Breast, and Inflammatory Breast Cancer.
Her clinical research consists of co-authoring 5 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
114 Woodland St, Hartford, CT 06105
Additional Areas of Focus
Dr. Mehra has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Yale University
Natalia Neparidze is a Hematologist and an Oncologist in New Haven, Connecticut. Dr. Neparidze is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). Her top areas of expertise are Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Aspiration, and Splenectomy.
Yale University
Katherine Harvey is an Oncologist and a Hematologist in Waterbury, Connecticut. Dr. Harvey is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). Her top areas of expertise are Angiosarcoma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Familial Colorectal Cancer, and Anal Cancer.
Regional Cancer Care Associates LLC
Joel Silver is a Hematologist and an Oncologist in Manchester, Connecticut. Dr. Silver is rated as an Advanced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Monoclonal Gammopathy of Undetermined Significance (MGUS), Schnitzler Syndrome, Multiple Myeloma, Bone Marrow Aspiration, and Myringotomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- AngiosarcomaDr. Mehra isDistinguished. Learn about Angiosarcoma.
- Breast CancerDr. Mehra isDistinguished. Learn about Breast Cancer.
- Paget Disease of the BreastDr. Mehra isDistinguished. Learn about Paget Disease of the Breast.
- Advanced
- BRCA Positive Breast CancerDr. Mehra isAdvanced. Learn about BRCA Positive Breast Cancer.
- Chronic Lymphocytic Leukemia (CLL)
- DICER1 SyndromeDr. Mehra isAdvanced. Learn about DICER1 Syndrome.
- HER-2 Positive Breast CancerDr. Mehra isAdvanced. Learn about HER-2 Positive Breast Cancer.
- HER2 Negative Breast CancerDr. Mehra isAdvanced. Learn about HER2 Negative Breast Cancer.
- Inflammatory Breast CancerDr. Mehra isAdvanced. Learn about Inflammatory Breast Cancer.
- Experienced
- Adult Immune ThrombocytopeniaDr. Mehra isExperienced. Learn about Adult Immune Thrombocytopenia.
- AgranulocytosisDr. Mehra isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung Cancer
- Anal CancerDr. Mehra isExperienced. Learn about Anal Cancer.
- AnemiaDr. Mehra isExperienced. Learn about Anemia.
- Breast Cancer in MenDr. Mehra isExperienced. Learn about Breast Cancer in Men.